Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?

Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?

Cancer multidrug resistance (MDR) is one of the main mechanisms contributing to therapy failure and mortality. Overexpression of drug transporters of the ABC family (ATP-binding cassette) is a major cause of MDR. Extracellular vesicles (EVs) are nanoparticles released by most cells of the organism i...

Full description

Bibliographic Details
Main Authors:	María Bucci-Muñoz, Aldana Magalí Gola, Juan Pablo Rigalli, María Paula Ceballos, María Laura Ruiz
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Life
Subjects:	ABC transporters drug resistance extracellular vesicles P-glycoprotein breast cancer resistance protein multidrug resistance-associated protein
Online Access:	https://www.mdpi.com/2075-1729/13/8/1633

Similar Items

Role of multidrug transporters in neurotherapeutics
by: Jose Manna, et al.
Published: (2009-01-01)

Functional Characterization of ABCC Proteins from Trypanosoma cruzi and Their Involvement with Thiol Transport
by: Kelli Monteiro da Costa, et al.
Published: (2018-02-01)

Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs)
by: José Pedro Gil, et al.
Published: (2021-11-01)

Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
by: Yena Cho, et al.
Published: (2020-06-01)

Natural products for combating multidrug resistance in cancer
by: Ting Chen, et al.
Published: (2024-04-01)

The Effects of Synthetically Modified Natural Compounds on ABC Transporters
by: Daniel Dantzic, et al.
Published: (2018-08-01)

Different Ability of Multidrug-Resistant and -Sensitive Counterpart Cells to Release and Capture Extracellular Vesicles
by: Diana Sousa, et al.
Published: (2021-10-01)

Overcoming Multidrug Resistance in Human Cancer Cells by Natural Compounds
by: Tomohiro Nabekura
Published: (2010-05-01)

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
by: Priya Yadav, et al.
Published: (2022-09-01)

Expression of multidrug-resistance associated proteins in human retinoblastoma treated by primary enucleation
by: Li-Juan Tang, et al.
Published: (2018-09-01)

Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo
by: Gangyang Wang, et al.
Published: (2022-01-01)

Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)
by: Juan Pablo Rigalli, et al.
Published: (2024-04-01)

The Relationship between Survival and Multidrug Resistance Protein 1
by: Kadir Öztürk, et al.
Published: (2013-12-01)

Expression of multidrug resistance proteins in retinoblastoma
by: Swati Shukla, et al.
Published: (2017-11-01)

Heat Shock Proteins Mediate Intercellular Communications within the Tumor Microenvironment through Extracellular Vesicles
by: Renata F. Saito, et al.
Published: (2024-01-01)

Swietephragmin D, a limonoid from Swietenia mahagoni, reverses multidrug resistance by inhibiting P-glycoprotein dependent efflux
by: Han Guo, et al.
Published: (2022-05-01)

Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy
by: Sonu Kumar Gupta, et al.
Published: (2020-07-01)

Glicoproteína-P, resistência a múltiplas drogas (MDR) e relação estrutura-atividade de moduladores P-glycoprotein and multidrug resistance: structure-activity relationships of modulators
by: Paula C. Huber, et al.
Published: (2010-01-01)

Importance of ABC Transporters in the Survival of Parasitic Nematodes and the Prospect for the Development of Novel Control Strategies
by: Ali Raza, et al.
Published: (2023-05-01)

Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5
by: Julia Sachs, et al.
Published: (2019-04-01)

The Emerging Roles of Extracellular Vesicles in Osteosarcoma
by: Francesca Perut, et al.
Published: (2019-12-01)

Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance
by: Huiqin Guo, et al.
Published: (2012-10-01)

Multidrug resistance-associated ABC transporters – too much of one thing, good for nothing
by: Prochazkova Jirina, et al.
Published: (2012-08-01)

Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide
by: Sara Ortiz-Rivero, et al.
Published: (2024-01-01)

Double-Coated Poly(butyl Cyanoacrylate) Nanoparticles as a Potential Carrier for Overcoming P-Gp- and BCRP-Mediated Multidrug Resistance in Cancer Cells
by: Neeraj Kaushal, et al.
Published: (2021-10-01)

Effects of Myristicin in Association with Chemotherapies on the Reversal of the Multidrug Resistance (MDR) Mechanism in Cancer
by: Elisa Frederico Seneme, et al.
Published: (2022-10-01)

Reversal of Ovarian Cancer Cell Lines Multidrug Resistance Phenotype by the Association of Apiole with Chemotherapies
by: Carolina Afonso de Lima, et al.
Published: (2020-10-01)

Intercellular transfer of P-glycoprotein mediates the formation of stable multi-drug resistance in human bladder cancer BIU-87 cells
by: Xiao-Zhi Cheng, et al.
Published: (2019-05-01)

Expression of Multidrug Resistance Genes in Peripheral Blood of Patients with Refractory Epilepsy and the Reverse Effect of Oxcarbazepine on Its Expression
by: Jinming JI, et al.
Published: (2017-12-01)

Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
by: Raúl Muñoz Velasco, et al.
Published: (2022-03-01)

The First Cytoplasmic Loop in the Core Structure of the ABCC1 (Multidrug Resistance Protein 1; MRP1) Transporter Contains Multiple Amino Acids Essential for Its Expression
by: Gwenaëlle Conseil, et al.
Published: (2021-09-01)

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
by: Ning Ji, et al.
Published: (2018-10-01)

Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells
by: Yuanyuan Zhou, et al.
Published: (2019-10-01)

Differential Action of Silver Nanoparticles on ABCB1 (MDR1) and ABCC1 (MRP1) Activity in Mammalian Cell Lines
by: Damian Krzyzanowski, et al.
Published: (2021-06-01)

ABCB1 Does Not Require the Side-Chain Hydrogen-Bond Donors Gln<sup>347</sup>, Gln<sup>725</sup>, Gln<sup>990</sup> to Confer Cellular Resistance to the Anticancer Drug Taxol
by: Keerthana Sasitharan, et al.
Published: (2021-08-01)

Identification of Novel Rare <i>ABCC1</i> Transporter Mutations in Tumor Biopsies of Cancer Patients
by: Onat Kadioglu, et al.
Published: (2020-01-01)

Marine Natural Products as Models to Circumvent Multidrug Resistance
by: Solida Long, et al.
Published: (2016-07-01)

The Roles of microRNAs in Cancer Multidrug Resistance
by: Lucia Pavlíková, et al.
Published: (2022-02-01)

Changes in Gene Expression Profiling and Phenotype in Aged Multidrug Resistance Protein 4-Deficient Mouse Retinas
by: Kyung Woo Kim, et al.
Published: (2021-03-01)

Involvement of CD147 on multidrug resistance through the regulation of P-glycoprotein expression in K562/ADR leukemic cell line
by: Aoranit Somno, et al.
Published: (2016-01-01)